Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imatinib Mesylate Therapy in Systemic Mastocytosis Patients Lacking KIT Mutations

NCT01297777 is registered in ClinicalTrials.gov with Hospital Virgen de la Salud as lead sponsor.

NCT NCT01297777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01297777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imatinib Mesylate Therapy in Systemic Mastocytosis Patients Lacking KIT Mutations
Lead sponsor
Hospital Virgen de la Salud
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
August 31, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic mastocytosis